Skip to main content
Articles & Publications , Dr. Andy Lewis

Video Interview: Dr. Andrew Lewis Discusses CMC Challenges for GLP-1 and Oral Peptides with PharmTech Europe

PharmTech.com and Pharmaceutical Technology Europe logos

In this video interview with PharmTech Europe, Dr. Andrew Lewis, Chief Scientific Officer at Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during his attendance at CPHI Milan.   

Watch the recent video with PharmTech Europe and Andy Lewis
Watch a recent video with PharmTech Europe and Andy Lewis.

Dr. Lewis talked about the chemistry, manufacturing, and control (CMC) challenges encountered during the development of glucagon-like peptide 1 (GLP-1) and oral peptides. 

Watch the full video and read the article on PharmTech Europe.

 

Latest news from Quotient Sciences

More News
Articles & Publications, Dr. Andy Lewis, AI, Clinical Trials The Future of Pharma: How AI is Transforming the Industry By: Dr. Andrew Lewis
Read More
formulation development, GLP-1, Peptides, Dr. Andy Lewis, Dr. Andrew Parker Video Interview: Dr. Andrew Lewis and Dr. Andrew Parker Speak with Manufacturing Chemist at CPHI Milan
Read More
Get in touch
Humanity can't afford to wait, so neither can we.